bioeconomyInsempra and Axxence launch alpha-iononePrecision fermentation specialist Insempra GmbH has inked a supply deal with Axxence Aromatic GmbH for alpha-Ionon, a natural flavour and fragance ingredient. more ➔
partnershipGerman-Chinese ADC collaborationBioNTech has entered the ADC field with an exclusive license and collaboration agreement with Chinas DualityBio Ltd for two antibody-drug conjugate (ADC) assets. more ➔
ProbioticsNomi Biotech presents natural additive to...Researchers from Polish-Japanese Nomi Biotech sp zoo have presented evidence that that probiotic yogurt can be conserved without artificial preservatives. more ➔
BiofuelAlgal enzyme synthesizes gasoline building...An algal photoenzyme that synthesizes medium-chain hydrocarbons – the building blocks of gasoline – is set to boost industrial-scale production of biofuels. more ➔
FundraisingLSP Dementia Fund closes at €260mEQT Life Sciences has closed the LSP Dementia Fund at approximately €260m, 2.6-fold over the target fund size of €100m. more ➔
partnershipSecarna Pharmaceuticals partners with SciN...Antisense drug developer Secarna Pharmaceuticals and CNS expert SciNeuro Pharmaceuticals have inked an R&D and licence option contract for CNS diseases. more ➔
Hot of the press: new issue of BIOTECH Ins...The latest issue of BIOTECH Insight newsletter of Deutsche Börse in collaboration with BIOCOM AG is out, covering hot topics of the German biotech sector. more ➔
immunoncologyMacomics licences macrophage modulator to...Edinburgh-based immuno-oncology expert Macomics Ltd has partnered with Ono Pharmaceutical to develop a macrophage-targeting antibody targetting cancer. more ➔
financingmbiomics GmbH cashes in €13m in Series A... Munich-based microbiome therapeutics specialist mbiomics GmbH has raised €13m in the first closing of Series A round led by MIG Capital. more ➔
CGTUpscaling AAV gene therapy Biovian Oy’s second generation AAV platform will include Remedium Bio Inc.’s lead treatment candidate against Osteoarthritis. more ➔
